Article Text

Download PDFPDF
Epidemiological characteristics and clinical course of eyelid squamous cell carcinoma patients from a large tertiary centre between 2009 and 2020
  1. Annemarie Klingenstein1,
  2. Christina Samel2,
  3. Elisabeth M Messmer1,
  4. Aylin Garip-Kuebler1,
  5. Siegfried G Priglinger1,
  6. Christoph R Hintschich1
  1. 1Department of Ophthalmology, Ludwig-Maximilians-University Munich, Munich, Bavaria, Germany
  2. 2Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Nordrhein-Westfalen, Germany
  1. Correspondence to Dr Annemarie Klingenstein, Department of Ophthalmology, Ludwig-Maximilians-Universitat Munchen, Munchen 80336, Germany; annemarie.klingenstein{at}med.uni-muenchen.de

Abstract

Background/aims To assess epidemiological tumour features, risk factors, clinical management and outcome of eyelid squamous cell carcinoma (SCC) and changes thereof. Furthermore, we searched for validating predictors of the American Joint Committee on Cancer (AJCC) 8 classification system.

Methods We evaluated data of 117 patients with histologically proven eyelid SCC at a large tertiary German university centre between January 2009 and March 2020. This retrospective, monocentric analysis included descriptive statistics and non-parametric tests (p<0.05).

Results Histologically controlled excision and follow-up was performed in 88 (75.2%) patients. In the remaining patients with higher T-category, individual adjuvant therapy combinations were initiated. We found higher numbers of nodal metastasis and recurrence for male patients and higher T-category (p=0.035, p=0.008 and p=0.001, p<0.001). Recurrence rates proved higher for patients with multiple lesions (p=0.008). Disease-specific survival (DSS) was 95.7% at 2 and 94.9% at 5 years of follow-up. Six patients (5.1%) died from eyelid SCC with nodal metastasis and higher T-category being negative prognostic factors (p<0.001 and p=0.009). Mortality was associated with tumour location in the medial upper eyelid, nodal metastasis being more frequent (p=0.001 and p=0.009) and tumour of the lower eyelid alone as positive predictor (p=0.012). T category differed in 34 (29.1%) patients when comparing AJCC 7 and 8 (p<0.001). Changes in T category as per the AJCC 8 classification resulted in better prediction of DSS (p=0.024).

Conclusion Special attention should be paid to male patients, tumour location in the upper medial eyelid and lymph node diagnostics. Prediction of DSS proved superior as per the AJCC 8 staging system.

  • epidemiology
  • eye lids
  • neoplasia

Statistics from Altmetric.com

Footnotes

  • Contributors All authors have contributed substantially to the present study. AK: Conception and design of the study, data acquisition, analysis, drafting of the work, final approval. CS: Data analysis, critical revision, final approval. EMM: Data acquisition, critical revision, final approval. AG-K: Critical revision, final approval. SGP: Critical revision, final approval. CRH: Data acquisition, critical revision, final approval.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval Institutional review board approval was obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Deidentified participant data are available from the corresponding author upon reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.